Bermingham Alun, Price Edmund, Marchand Christophe, Chergui Adel, Naumova Alena, Whitson Emily L, Krumpe Lauren R H, Goncharova Ekaterina I, Evans Jason R, McKee Tawnya C, Henrich Curtis J, Pommier Yves, O'Keefe Barry R
Molecular Targets Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.
Laboratory of Molecular Pharmacology, Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
SLAS Discov. 2017 Oct;22(9):1093-1105. doi: 10.1177/2472555217717200. Epub 2017 Jul 11.
Tyrosyl-DNA phosphodiesterase 1 (TDP1) is an enzyme crucial for cleavage of the covalent topoisomerase 1-DNA complex, an intermediate in DNA repair. TDP1 plays a role in reversing inhibition of topoisomerase I by camptothecins, a series of potent and effective inhibitors used in the treatment of colorectal, ovarian, and small-cell lung cancers. It is hypothesized that inhibition of TDP1 activity may enhance camptothecin sensitivity in tumors. Here, we describe the design, development, and execution of a novel assay to identify inhibitors of TDP1 present in natural product extracts. The assay was designed to address issues with fluorescent "nuisance" molecules and to minimize the detection of false-positives caused by polyphenolic molecules known to nonspecifically inhibit enzyme activity. A total of 227,905 purified molecules, prefractionated extracts, and crude natural product extracts were screened. This yielded 534 initial positives (0.23%). Secondary prioritization reduced this number to 117 (0.05% final hit rate). Several novel inhibitors have been identified showing micromolar affinity for human TDP1, including halenaquinol sulfate, a pentacyclic hydroquinone from the sponge sp.
酪氨酰 - DNA磷酸二酯酶1(TDP1)是一种对切割共价拓扑异构酶1 - DNA复合物至关重要的酶,该复合物是DNA修复过程中的一个中间体。TDP1在逆转喜树碱对拓扑异构酶I的抑制作用中发挥作用,喜树碱是一系列用于治疗结直肠癌、卵巢癌和小细胞肺癌的强效有效抑制剂。据推测,抑制TDP1活性可能会增强肿瘤对喜树碱的敏感性。在此,我们描述了一种新型检测方法的设计、开发和实施,用于鉴定天然产物提取物中存在的TDP1抑制剂。该检测方法旨在解决荧光“干扰”分子的问题,并尽量减少已知会非特异性抑制酶活性的多酚类分子导致的假阳性检测。总共筛选了227,905种纯化分子、预分级提取物和天然产物粗提物。这产生了534个初始阳性结果(0.23%)。二次筛选将这个数字减少到117个(最终命中率0.05%)。已经鉴定出几种对人TDP1具有微摩尔亲和力的新型抑制剂,包括来自海绵Halenaquinol sulfate的五环对苯二酚。